Javier San Martin

(DR. Javier San Martin M.D.)

Currently holds a position at Arrowhead Pharmaceuticals Inc

Positions

Position Company Period
Chief Medical Officer Arrowhead Pharmaceuticals Inc Nov. 18, 2019 -
Vice President - Clinical Development Ultragenyx Pharmaceutical Inc Dec. 1, 2013 - Jan. 1, 2014
Javier San Martin's trades of Athira Pharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-03 2025-01-02
S Sale
10,826 -23.2%
0.56
USD 6,083 		10,826 -23.2% 0.56 USD 6,083
2024-01-08 2024-01-05
PS Planned sale
4,403 -2.2%
35.64
USD 156,923 		4,403 -2.2% 35.64 USD 156,923
2024-01-08 2024-01-05
PS Planned sale
3,100 -1.5%
35.03
USD 108,593 		3,100 -1.5% 35.03 USD 108,593
2024-01-08 2024-01-05
PS Planned sale
800 -0.4%
34.11
USD 27,288 		800 -0.4% 34.11 USD 27,288
2023-11-22 2023-11-20
S Sale
4,942 -3.6%
29.00
USD 143,318 		4,942 -3.6% 29.00 USD 143,318
2023-11-22 2023-11-20
S Sale
14,758 -9.7%
28.73
USD 423,997 		14,758 -9.7% 28.73 USD 423,997
2022-11-22 2022-11-21
PS Planned sale
200 -0.2%
30.62
USD 6,124 		200 -0.2% 30.62 USD 6,124
2022-11-22 2022-11-21
PS Planned sale
19,300 -17.4%
29.98
USD 578,614 		19,300 -17.4% 29.98 USD 578,614
2021-11-22 2021-11-19
PS Planned sale
100 -0.1%
70.99
USD 7,099 		100 -0.1% 70.99 USD 7,099
2021-11-22 2021-11-19
PS Planned sale
5,696 -4.9%
70.01
USD 398,777 		5,696 -4.9% 70.01 USD 398,777
2021-11-22 2021-11-19
PS Planned sale
13,704 -10.5%
69.01
USD 945,713 		13,704 -10.5% 69.01 USD 945,713
2020-11-20 2020-11-19
PS Planned sale
19,500 -13.0%
69.39
USD 1,353,105 		19,500 -13.0% 69.39 USD 1,353,105
// ... existing code ... // ... rest of the file ...